Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients
2024 Standout
2 intermediate papers

Works of Kyle Perry being referenced

Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma
2008

Author Peers

Author Last Decade Papers Cites
Kyle Perry 157 111 324 245 26 577
Pamela Tabaczka 206 91 323 226 32 730
Linda N. Dao 123 54 236 243 28 692
Vanessa Szablewski 110 44 284 222 44 546
Emanuele S. G. d'Amore 109 94 328 227 25 707
S Kumar 224 148 267 299 15 641
Anne F. Lauritzen 130 56 328 263 38 678
Itsuko Nakamichi 69 73 299 265 28 667
Sung Sik Shin 112 49 333 206 21 631
Liliana Calabrese 106 72 359 184 29 728
Talvalkar Gv 146 52 568 269 26 731

All Works

Loading papers...

Rankless by CCL
2026